Scrip | What Does 2023 Hold for Biopharma? Part 6: Artificial Intelligence

Feb 2023

Originally posted by Scrip on February 10, 2023.

Tony Crisman, Managing Director in Lincoln’s Healthcare Group, shares his predictions for artificial intelligence in the biopharma industry.

View the original article.

Summary

Contributor

Meet Professionals with Complementary Expertise

Related Perspectives

Beauty Outlook: Optimism for an Attractive 2023

Many investors are eyeing the year ahead for the beauty and personal care industry as it is ripe for accelerated growth due to several factors. 2022 had a key focus… Read More

Aerospace and Defense: Factors Powering M&A Activity

Lincoln International was pleased to speak on the Reshaping the Supply Chain Landscape: M&A Trends panel at Aviation Week Network’s A&D Supply Chain conference. During the panel, industry experts revealed… Read More

Lincoln International’s Global Packaging Team Reports Strong 2022 and Continued Demand for Packaging in 2023

Packaging activity in 2022 was strong but experienced a continued cooling as the year finished. While the latter half of this year showed a decline in the total number of… Read More

U.S. Distribution M&A Continues in an Evolving Market

Macroeconomic uncertainty, particularly the combination of widespread price inflation (and the Federal Reserve’s response to it) and expectations for a downturn in 2023, have eroded investor confidence since mid-2022, driving… Read More